EIVPX | JHQCX | EIVPX / JHQCX | |
Total Expense Ratio | 0.47 | 1.33 | 35% |
Annual Report Gross Expense Ratio | 0.47 | 1.33 | 35% |
Fund Existence | 8 years | 12 years | - |
Gain YTD | 4.410 | 0.825 | 535% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.13B | 21.2B | 5% |
Annual Yield % from dividends | 2.25 | 0.07 | 3,320% |
Returns for 1 year | 8.76 | 5.53 | 158% |
Returns for 3 years | 28.28 | 35.95 | 79% |
Returns for 5 years | 49.12 | 51.17 | 96% |
Returns for 10 years | N/A | 103.47 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 16.53 | 0.68 | +4.28% |
ProShares UltraShort Nasdaq Biotech | |||
EVSB | 50.90 | 0.02 | +0.04% |
Eaton Vance Ultra-Short Income ETF | |||
PCEF | 19.66 | -0.03 | -0.15% |
Invesco CEF Income Composite ETF | |||
FLSW | 37.58 | -0.32 | -0.83% |
Franklin FTSE Switzerland ETF | |||
DFAC | 36.11 | -0.33 | -0.91% |
Dimensional US Core Equity 2 ETF |